
Aulisa Medical USA, Inc. is a medical device company founded in 2012, specializing in FDA cleared, wireless, wearable patient monitoring systems. Based in Palo Alto, California, Aulisa focuses on continuous, cloud-based vital sign monitoring for infants, children, and adults. Their products leverage artificial intelligence and digital health technologies to provide real-time alerts for inconsistencies in vital sign data, facilitating early detection and intervention for health issues. Aulisa's innovative solutions aim to reduce the manual burden of vital sign monitoring for clinicians and caregivers, enhancing patient care and safety.

Aulisa Medical USA, Inc. is a medical device company founded in 2012, specializing in FDA cleared, wireless, wearable patient monitoring systems. Based in Palo Alto, California, Aulisa focuses on continuous, cloud-based vital sign monitoring for infants, children, and adults. Their products leverage artificial intelligence and digital health technologies to provide real-time alerts for inconsistencies in vital sign data, facilitating early detection and intervention for health issues. Aulisa's innovative solutions aim to reduce the manual burden of vital sign monitoring for clinicians and caregivers, enhancing patient care and safety.
Founded: 2012
Headquarters (operational): Taipei, Taiwan; U.S. subsidiary in Palo Alto, CA
Product: FDA-cleared wireless, wearable continuous vital-sign monitoring systems
Employee count: 9
Known investor: WI Harper Group
Reported total funding: USD 13,000,000
Clinical patient monitoring; early detection of physiological deterioration; reducing manual vital-sign checks.
2012
Medical devices; Digital health
Seed round recorded circa 2014
Series A announced January 12, 2022
“WI Harper Group listed among investors”